GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biocorp Production SA (FRA:8BP) » Definitions » EV-to-EBIT

Biocorp Production (FRA:8BP) EV-to-EBIT : -185.89 (As of May. 11, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Biocorp Production EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Biocorp Production's Enterprise Value is €157.64 Mil. Biocorp Production's EBIT for the trailing twelve months (TTM) ended in Dec. 2022 was €-0.85 Mil. Therefore, Biocorp Production's EV-to-EBIT for today is -185.89.

The historical rank and industry rank for Biocorp Production's EV-to-EBIT or its related term are showing as below:

FRA:8BP' s EV-to-EBIT Range Over the Past 10 Years
Min: -185.89   Med: -86.94   Max: 884.6
Current: -185.89

During the past 11 years, the highest EV-to-EBIT of Biocorp Production was 884.60. The lowest was -185.89. And the median was -86.94.

FRA:8BP's EV-to-EBIT is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 20.82 vs FRA:8BP: -185.89

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Biocorp Production's Enterprise Value for the quarter that ended in Dec. 2022 was €96.36 Mil. Biocorp Production's EBIT for the trailing twelve months (TTM) ended in Dec. 2022 was €-0.85 Mil. Biocorp Production's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2022 was -0.88%.


Biocorp Production EV-to-EBIT Historical Data

The historical data trend for Biocorp Production's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biocorp Production EV-to-EBIT Chart

Biocorp Production Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -90.28 697.52 -116.74

Biocorp Production Semi-Annual Data
Dec12 Dec13 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -90.28 - 697.52 - -116.74

Competitive Comparison of Biocorp Production's EV-to-EBIT

For the Medical Devices subindustry, Biocorp Production's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biocorp Production's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biocorp Production's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Biocorp Production's EV-to-EBIT falls into.



Biocorp Production EV-to-EBIT Calculation

Biocorp Production's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=157.637/-0.848
=-185.89

Biocorp Production's current Enterprise Value is €157.64 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Biocorp Production's EBIT for the trailing twelve months (TTM) ended in Dec. 2022 was €-0.85 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biocorp Production  (FRA:8BP) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Biocorp Production's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2022 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2022 ) =EBIT / Enterprise Value (Q: Dec. 2022 )
=-0.848/96.357108
=-0.88 %

Biocorp Production's Enterprise Value for the quarter that ended in Dec. 2022 was €96.36 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Biocorp Production's EBIT for the trailing twelve months (TTM) ended in Dec. 2022 was €-0.85 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biocorp Production EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Biocorp Production's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Biocorp Production (FRA:8BP) Business Description

Traded in Other Exchanges
N/A
Address
Technological Park Lavaur la Bechade, Issoire, FRA, 63500
Biocorp Production SA is engaged in the development, production, and marketing of medical devices and drug delivery systems for the pharmaceutical industry.

Biocorp Production (FRA:8BP) Headlines

No Headlines